iDtheinvestordatabase
Home / Directory / o2h Ventures
Likely active: new deal Nov 2025 Verified 4 Nov 2026

o2h Ventures

Cambridge-based biotech specialist manager of SEIS, EIS and Knowledge Intensive EIS funds that back UK human health companies in drug discovery, therapeutics and AI-enabled life science, from seed to growth stage, operating from its Mill SciTech Park.

Type
SEIS/EIS fund
Location
Cambridge, United Kingdom
Stages
Seed, Growth
Backs
Biotech and pharma
Sectors
Biotech, Healthtech and life sciences, AI, Deep tech
SEIS / EIS
SEIS and EIS
Fund size / AUM
Total manager AUM £8.05M (own fund pages); open EIS Growth Fund targets £10M
Portfolio mix
Biotech and pharma 70%; Deep tech 10%; Medtech and digital health 10%; Fintech 7%; B2B software 3% (n=30)

Contacts on file

For o2h Ventures, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.

Get UK Complete, $149 Free sample

One-time payment. No subscription. No account.

Notable investments

Hawkhill TherapeuticsHelus PharmaAtelerix

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 23 lists